跳至主要内容
临床试验/NCT06248736
NCT06248736已完成不适用

Description of Lactulose Administration by Balloon Rectal Tube in Severe Hepatic Encephalopathy

University Hospital, Grenoble1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2022年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
1
主要终点
Describe ammonia during lactulose administration by balloon rectal tube

研究概览

简要总结

Acute liver failure in cirrhotic patients is associated with a one-month mortality of 48%. Encephalopathy, largely related to hyperammonemia, is a frequent complication of liver failure and is a poor prognostic marker. Lactulose decreases ammonia by acidification of the colon, replacement of urease-producing bacteria and creation of a laxative effect. Thus, the administration of lactulose in patients with severe hepatic encephalopathy reduces mortality by more than 40%.

In intensive care patients, lactulose is often administered rectally. The use of simple rectal tubes is associated with frequent leakage of lactulose as well as faecal discharge and therefore risks of infection and skin lesions. Balloon rectal tubes with a drug delivery valve have recently been developed and used in this indication. The aim of this study is therefore to describe the use of these balloon rectal tubes to administer Lactulose in severe hepatic encephalopathy.

This suggests that ammonia reduction in these patients may prolong survival time.

No studies have described the administration of Lactulose via the rectal route with a balloon tube. The descriptive methodology is therefore appropriate. This is a preliminary study allowing data collection to establish the methodology for a subsequent clinical trial.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • > 18 years
  • Patients treated with Lactulose with balloon rectal probe

排除标准

  • Patient(s) objecting to the use of their data for research purposes
  • Rectal probe contraindication: damage to the rectal mucosa, rectal surgery, severe haemorrhoids, rectal stenosis, rectal tumour,
  • Lactulose contraindication (person unable to absorb galactose)
  • Patients deprived of liberty, under guardianship or curators
  • Pregnant women
  • Patient not affiliated to a social security scheme

结局指标

主要结局

Describe ammonia during lactulose administration by balloon rectal tube

时间窗: 48 hours

Variation of ammonia before treatment and after 48h of treatment

次要结局

  • Describe the neurological course following administration of lactulose via a balloon rectal tube(at 7 days)
  • Describe ammonia levels after lactulose administration via balloon rectal tube.(at 7 days)
  • Describe the skin tolerance of patients during hospitalization.(at 7 days)
  • Describe complications related to the balloon rectal tube(at 7 days)
  • Describe complications related to rectal lactulose administration(at 7 days)
  • Patient outcomes(at 28 days)
  • Caregiver satisfaction(at 7 days)
  • Describe balloon rectal probe retention(at 7 days)

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验